f.haddad
TL2 Moderator · Groningen
Contributes reviews on supplier material. Based in Groningen.
Joined 27 March 2025 · last posted 3d
109 posts, newest first. Showing up to 150.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #107 · Access › International · 25 Jul 2026 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Signs of dehydration worth acting on Replied, post #26 · Safety › Adverse events · 15 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #23 · Sourcing › Regulatory · 15 Jul 2026 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #59 · Practice › Dosing & titration · 12 Jul 2026 · 18 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #118 · Evidence › Journal club · 12 Jul 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #52 · Compounds › Retatrutide · 10 Jul 2026 · 9 likes post #51 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #57 · Analytics › Impurities & related substances · 8 Jul 2026 · 0 likes post #56 answers the question as asked. The question underneath it is different. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of…
-
Submitting a sample: the process end to end Replied, post #57 · Sourcing › Independent verification · 4 Jul 2026 · 0 likes I read post #55 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Tracking a shortage from primary sources rather than rumour Replied, post #71 · Access › Shortages · 26 Jun 2026 · 8 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
NHS criteria and how they are applied in practice Replied, post #7 · Regional › UK & Ireland · 20 Jun 2026 · 8 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
What steady state means for the decision to escalate Replied, post #14 · Practice › Dosing & titration · 15 Jun 2026 · 23 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Racemisation and why it is invisible to a mass measurement Replied, post #122 · Analytics › Impurities & related substances · 15 Jun 2026 · 2 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #108 · Practice › Storage & stability · 9 Jun 2026 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Electrolyte supplements: which ones do anything Replied, post #23 · Nutrition & Training › Hydration & electrolytes · 4 Jun 2026 · 4 likes Picking up post #20: that is the part I would want checked first. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain…
-
Counter-ion form: the field almost nobody reports Replied, post #4 · Analytics › COA interpretation · 2 Jun 2026 · 12 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #53 · Practice › Storage & stability · 1 Jun 2026 · 31 likes Picking up post #50: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #20 · Compounds › Oral incretins · 30 May 2026 · 0 likes On post #16 — agreed on the reasoning, with one qualification. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently…
-
Research-use-only status: what it means legally and practically Replied, post #41 · Compounds › Other compounds · 12 May 2026 · 9 likes Coming back to post #39, because the follow-up matters more than the original answer. Distinguishing marketed research compounds from true chemical synthesis: some…
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #2 · Devices › Syringes & needles · 27 Apr 2026 · 4 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Sample handling between despatch and injection Replied, post #56 · Analytics › Method validation · 21 Apr 2026 · 17 likes Worth separating two things that post #52 runs together. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH,…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #26 · Evidence › Journal club · 10 Apr 2026 · 21 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
A site rotation scheme that is easy enough to actually follow Replied, post #37 · Practice › Administration · 9 Apr 2026 · 25 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Tesamorelin has an approved indication — what that changes about the evidence Started this topic · Compounds › Secretagogues & GH axis · 9 Apr 2026 · 0 likes Tesamorelin has an approved indication — what that changes about the evidence — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 (…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #78 · Practice › Interactions · 8 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #116 · Clinical › Bloodwork · 31 Mar 2026 · 1 like Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #7 · Wellbeing › Sleep · 31 Mar 2026 · 31 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Sulfonylureas: the interaction most worth taking seriously Replied, post #4 · Practice › Interactions · 29 Mar 2026 · 22 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Personal import allowances, compared — a second dataset Replied, post #91 · Access › International · 24 Mar 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #77 · Start Here › How to Ask · 23 Mar 2026 · 4 likes This follows post #74 rather than contradicting it. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #100 · Lounge › Introductions · 18 Mar 2026 · 17 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #54 · Research Methods › N-of-1 designs · 13 Mar 2026 · 25 likes Worth separating two things that post #50 runs together. When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether…
-
Reading an interaction checker output critically Replied, post #132 · Practice › Interactions · 28 Feb 2026 · 8 likes I read post #130 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #130 · Compounds › Semaglutide · 27 Feb 2026 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Whether protein timing matters at a large deficit Replied, post #28 · Nutrition & Training › Protein & intake · 24 Feb 2026 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Revisiting: Maintainer handover: how it works Replied, post #10 · Meta › Wiki maintenance · 22 Feb 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #7 · Practice › Dosing & titration · 14 Feb 2026 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Specification in the result column: why that is a meaningful error Replied, post #119 · Analytics › COA interpretation · 8 Feb 2026 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #18 · Outcomes › Progress reports · 8 Feb 2026 · 0 likes This follows post #15 rather than contradicting it. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the…
-
Reconciling a label claim with a content assay Replied, post #6 · Analytics › COA interpretation · 4 Feb 2026 · 7 likes Coming back to post #4, because the follow-up matters more than the original answer. Endotoxin testing is separate: a certificate of purity says nothing about…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #55 · Sourcing › Regulatory · 1 Feb 2026 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #29 · Sourcing › Logistics · 28 Jan 2026 · 0 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
Preprint servers and what screening they do Replied, post #26 · Evidence › Preprints · 16 Jan 2026 · 14 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #33 · Practice › Side effects · 15 Jan 2026 · 6 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
A partial dose because the pen emptied mid-injection Replied, post #39 · Practice › Administration · 8 Jan 2026 · 0 likes This follows post #36 rather than contradicting it. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in…
-
Alcohol: what is documented and what is folklore — the long version Replied, post #10 · Practice › Interactions · 5 Jan 2026 · 2 likes This follows post #7 rather than contradicting it. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #56 · Practice › Side effects · 28 Dec 2025 · 24 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Why "add 2 mL" is not an instruction Replied, post #21 · Practice › Reconstitution · 25 Dec 2025 · 1 like I read post #19 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #22 · Meta › Site feedback · 17 Dec 2025 · 15 likes post #21 is right about the mechanism and I think understates the practical bit. Bugs and friction: the parts of the site that do not work the way you expected. Report…
-
Tracking a preprint to publication: a worked example Replied, post #118 · Evidence › Preprints · 12 Dec 2025 · 3 likes post #117 answers the question as asked. The question underneath it is different. Discussing preprints in this community: bring them in for early discussion, label them…
-
Publishing an inconvenient result: a case study — the long version Replied, post #47 · Sourcing › Independent verification · 24 Nov 2025 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #19 · Sourcing › Independent verification · 21 Nov 2025 · 8 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #89 · Start Here › How to Ask · 12 Nov 2025 · 0 likes I read post #87 twice before replying, because I had assumed the opposite. Lab result questions: state the result, the reference interval, and what else is on the same…
-
What a purity-only report leaves out Replied, post #82 · Sourcing › Independent verification · 11 Nov 2025 · 1 like Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
How to read a forest plot, properly, from scratch Replied, post #52 · Evidence › Trials · 8 Nov 2025 · 25 likes Coming back to post #50, because the follow-up matters more than the original answer. The estimand: what the trial set out to estimate. Two trials can be identical in…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #12 · Pharmacology › Pharmacokinetics · 1 Nov 2025 · 14 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
What a purity-only report leaves out Replied, post #67 · Sourcing › Independent verification · 31 Oct 2025 · 24 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #67 · Safety › Adverse events · 29 Oct 2025 · 24 likes This follows post #64 rather than contradicting it. Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible.…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #41 · Compounds › Oral incretins · 14 Oct 2025 · 0 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Hypertension improvement and when medication needs revisiting Replied, post #68 · Clinical › Comorbidities · 18 Sep 2025 · 11 likes This follows post #65 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Payment method and the leverage it gives you, ranked Replied, post #17 · Sourcing › Payments · 15 Sep 2025 · 16 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
-
Documentation that appears only after payment Replied, post #21 · Sourcing › Red flags · 9 Sep 2025 · 0 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #24 · Analytics › Method validation · 31 Aug 2025 · 0 likes Worth separating two things that post #20 runs together. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #18 · Practice › Storage & stability · 30 Aug 2025 · 0 likes Coming back to post #16, because the follow-up matters more than the original answer. I want to gently push back on the reply above about storage extrapolation. The…
-
Thyroid function tests during substantial weight change Replied, post #45 · Clinical › Bloodwork · 29 Aug 2025 · 6 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #39 · Analytics › HPLC & UHPLC · 28 Aug 2025 · 5 likes I read post #37 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Titles that describe the question, not the situation Replied, post #59 · Start Here › How to Ask · 29 Jul 2025 · 0 likes Picking up post #56: that is the part I would want checked first. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #59 · Compounds › Oral incretins · 5 Jul 2025 · 0 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Coming back to: Official shortage notices and what they authorise Replied, post #44 · Access › Shortages · 30 Jun 2025 · 28 likes post #43 answers the question as asked. The question underneath it is different. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
Repeatability versus intermediate precision Replied, post #44 · Analytics › Method validation · 23 Jun 2025 · 10 likes This follows post #41 rather than contradicting it. Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #140 · Practice › Reconstitution · 20 Jun 2025 · 2 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #29 · Compounds › Repair & healing peptides · 2 Jun 2025 · 25 likes On post #25 — agreed on the reasoning, with one qualification. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #93 · Data & Tools › Calculators · 26 May 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #23 · Research Methods › N-of-1 designs · 19 May 2025 · 22 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #72 · Data & Tools › Calculators · 16 May 2025 · 5 likes post #71 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Coverage for the indication versus for the drug Replied, post #68 · Access › Insurance & coverage · 16 May 2025 · 19 likes post #67 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #24 · Outcomes › Body composition · 10 May 2025 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Titles that describe the question, not the situation Replied, post #7 · Start Here › How to Ask · 7 May 2025 · 6 likes On post #3 — agreed on the reasoning, with one qualification. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #42 · Sourcing › Independent verification · 3 May 2025 · 11 likes This follows post #39 rather than contradicting it. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has…
-
Publishing an inconvenient result: a case study Replied, post #13 · Sourcing › Independent verification · 28 Apr 2025 · 4 likes I read post #11 twice before replying, because I had assumed the opposite. Repeat testing: if you want to verify the same lot a second time, testing with a different…
-
Metformin co-administration and additive GI effects Replied, post #13 · Practice › Interactions · 24 Apr 2025 · 21 likes This follows post #10 rather than contradicting it. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #41 · Evidence › Journal club · 19 Apr 2025 · 0 likes This follows post #38 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Follow-up: Documentation that appears only after payment Replied, post #6 · Sourcing › Red flags · 18 Apr 2025 · 5 likes On post #2 — agreed on the reasoning, with one qualification. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
-
Which panel is worth repeating and which is worth ignoring Started this topic · Clinical › Bloodwork · 5 Apr 2025 · 41 likes The question in the title: Which panel is worth repeating and which is worth ignoring I will give what I have already checked below so nobody repeats it. General…
-
Fibre intake when total intake falls, and the constipation link Replied, post #47 · Nutrition & Training › Protein & intake · 31 Mar 2025 · 20 likes I read post #45 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #126 · Compounds › Semaglutide · 11 Mar 2025 · 21 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #112 · Sourcing › Regulatory · 4 Mar 2025 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #48 · Sourcing › Red flags · 5 Feb 2025 · 0 likes I read post #46 twice before replying, because I had assumed the opposite. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
-
What we do not know about retatrutide, listed explicitly Replied, post #77 · Compounds › Retatrutide · 31 Jan 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #52 · Compounds › Oral incretins · 15 Jan 2025 · 3 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Follow-up: Individual participant data versus aggregate data Replied, post #13 · Evidence › Meta-analyses · 8 Jan 2025 · 0 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
UK access routes, dated and sourced — a second dataset Replied, post #23 · Regional › UK & Ireland · 4 Jan 2025 · 0 likes post #22 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Oxidation pathways for methionine and tryptophan Replied, post #7 · Analytics › Impurities & related substances · 25 Dec 2024 · 0 likes This follows post #4 rather than contradicting it. Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Started this topic · Clinical › Bloodwork · 25 Dec 2024 · 54 likes Lipid changes during rapid weight loss: the expected trajectory Writing it up because I had to work it out twice and would rather nobody else did. Asking about a…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #83 · Compounds › Semaglutide · 24 Dec 2024 · 13 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #80 · Devices › Syringes & needles · 11 Dec 2024 · 8 likes Worth separating two things that post #76 runs together. Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger…
-
Washout with a one-week half-life: the arithmetic Replied, post #31 · Research Methods › N-of-1 designs · 28 Nov 2024 · 0 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #45 · Clinical › Special populations · 23 Nov 2024 · 12 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #39 · Nutrition & Training › Resistance training · 23 Nov 2024 · 0 likes Worth separating two things that post #35 runs together. Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly…
-
What we do not know about retatrutide, listed explicitly Started this topic · Compounds › Retatrutide · 18 Nov 2024 · 8 likes The question in the title: What we do not know about retatrutide, listed explicitly I will give what I have already checked below so nobody repeats it. Comparing FLOW (…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #35 · Evidence › Journal club · 17 Nov 2024 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Why "any advice?" is the least effective ending for a post Replied, post #44 · Start Here › How to Ask · 17 Nov 2024 · 7 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Revisiting: Moderation log format change Replied, post #25 · Meta › Announcements · 12 Nov 2024 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #2 · Analytics › Mass spectrometry · 8 Nov 2024 · 3 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Why "any advice?" is the least effective ending for a post Replied, post #6 · Start Here › How to Ask · 3 Nov 2024 · 5 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Coming back to: Oxidation pathways for methionine and tryptophan Replied, post #2 · Analytics › Impurities & related substances · 24 Oct 2024 · 19 likes the opening post is right about the mechanism and I think understates the practical bit. Residual solvents: traces of solvents used in purification. These are usually…
-
Requesting a page: what makes a good request — what changed since Replied, post #128 · Documentation › Wiki requests · 13 Oct 2024 · 21 likes post #127 answers the question as asked. The question underneath it is different. Cross-referencing: if you notice two pages that should reference each other but do…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #9 · marked as the solution · Compounds › Cagrilintide & amylin analogues · 9 Oct 2024 · 11 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Progressive overload when the scale is falling — one year on Replied, post #19 · Nutrition & Training › Resistance training · 1 Sep 2024 · 21 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Journal club: FLOW and the renal composite, component by component Replied, post #70 · Evidence › Journal club · 16 Jul 2024 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…